蒙脱石散联用双歧杆菌四联活菌片治疗小儿腹泻疗效观察

The clinical efficacy of Montmorillonite powder and Bifidobacterium Tetravaccine tablets for the treatment of infantile diarrhea

目的:分析蒙脱石散和双歧杆菌四联活菌片联合治疗小儿腹泻的临床疗效。方法:将180例小儿腹泻患者随机分为两组,对照组患儿用双歧杆菌四联活菌片治疗,观察组患儿联合应用蒙脱石散与双歧杆菌四联活菌片治疗,分析其临床效果并进行对比。结果:观察组患儿的总有效率和不良反应发生率分别为96. 67%、1. 1%;对照组患儿的总有效率和不良反应发生率分别为81. 11%、13. 3%,两组对比,差异有统计学意义(P <0. 05)。结论:小儿腹泻联合应用蒙脱石散与双歧杆菌四联活菌片治疗临床效果良好,可以在临床进行推广。

Objective To analyze the clinical efficacy of Montmorillonite powder and Bifidobacterium Tetravaccine tablets for the treatment of infantile diarrhea. Method 180 cases of infantile diarrhea patients were randomly divided into two groups, the control group were with Bifidobacterium Tetravaccine tablets treatment, observation group with combined application of Montmoril- lonite powder and Bifidobacterium tetragenous viable bacteria treatment, the clinical efficacy was analyzed. Results In the obser- vation group, the total occurrence rate and adverse reaction rate were 96. 67% , 1.1% , respectively, in the control group,the total occurrence rate and adverse reaction rate were 81.11% , 13.3% , respectively, lwo groups had significant differences, there were statistical significance （ P 〈 0. 05 ）. Conclusion Infantile diarrhea combined application of Montmorillonite powder and Bifidobacterium Tetravaccine tablets in the treatment of clinical effect is good, can be used.